Published in J Immunol on October 01, 1984
What's new about hay fever? Br Med J (Clin Res Ed) (1985) 1.76
Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation. J Leukoc Biol (2011) 1.44
Uteroglobin represses allergen-induced inflammatory response by blocking PGD2 receptor-mediated functions. J Exp Med (2004) 1.36
Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol (1987) 1.24
Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med (2003) 1.12
The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma. Br J Clin Pharmacol (1988) 1.09
Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology (1999) 1.06
9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. J Clin Invest (1987) 1.02
Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5'-monophosphate in non-atopic asthma. Thorax (1987) 1.00
Induction of tryptase and histamine release from human colon mast cells by IgE dependent or independent mechanisms. World J Gastroenterol (2004) 0.91
Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol (1989) 0.88
Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity. Clin Exp Immunol (1986) 0.86
Prostaglandin D2 release from human skin mast cells in response to ionophore A23187. Br J Pharmacol (1987) 0.83
Oxidative transformations of arachidonic acid in human dispersed lung cells: disparity between the utilization of endogenous and exogenous substrate. Br J Pharmacol (1985) 0.82
Immunological and non-immunological release of leukotrienes and histamine from human nasal polyps. Clin Exp Immunol (1986) 0.82
Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man. Br J Pharmacol (1986) 0.81
The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C. Br J Pharmacol (1990) 0.79
The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. Br J Pharmacol (1988) 0.79
Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4. Thorax (1997) 0.79
Overview of allergic mechanisms. Ebastine has more than an antihistamine effect. Drugs (1996) 0.75
Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma. Eur Arch Otorhinolaryngol (1994) 0.75
Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease. Inflammation (2013) 0.75
Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med (1990) 7.46
Sulfonamide resistance gene for plant transformation. Plant Mol Biol (1990) 6.28
A self management plan in the treatment of adult asthma. Thorax (1989) 5.85
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med (1999) 4.72
Mucosal inflammation in asthma. Am Rev Respir Dis (1990) 4.11
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10
Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis (1989) 3.86
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Overlapping functions of components of a bacterial Sec-independent protein export pathway. EMBO J (1998) 3.59
Transport of proteins into chloroplasts. Partial purification of a chloroplast protease involved in the processing of important precursor polypeptides. Eur J Biochem (1984) 3.30
Prevalence of respiratory symptoms among 7 and 11 year old schoolchildren and association with asthma. Arch Dis Child (1989) 3.25
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol (1996) 2.92
An essential component of a novel bacterial protein export system with homologues in plastids and mitochondria. J Biol Chem (1998) 2.86
Rhinoviruses infect the lower airways. J Infect Dis (2000) 2.83
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73
Export of active green fluorescent protein to the periplasm by the twin-arginine translocase (Tat) pathway in Escherichia coli. Mol Microbiol (2001) 2.71
Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest (1999) 2.53
Protection against allergen-induced asthma by salmeterol. Lancet (1990) 2.51
Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med (1995) 2.48
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis (1990) 2.45
Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J (2000) 2.42
Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study. BMJ (1997) 2.40
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34
Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am J Respir Cell Mol Biol (1995) 2.30
A new type of signal peptide: central role of a twin-arginine motif in transfer signals for the delta pH-dependent thylakoidal protein translocase. EMBO J (1995) 2.29
Personal exposures of children to nitrogen dioxide relative to concentrations in outdoor air. Occup Environ Med (2000) 2.29
Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ (1992) 2.25
Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res (1993) 2.22
Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax (1984) 2.20
The genetic analysis of bacterial spore germination. J Appl Bacteriol (1994) 2.19
Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 2.19
Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest (1998) 2.13
TatB and TatC form a functional and structural unit of the twin-arginine translocase from Escherichia coli. J Biol Chem (2001) 2.11
TatD is a cytoplasmic protein with DNase activity. No requirement for TatD family proteins in sec-independent protein export. J Biol Chem (2000) 2.10
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol (1983) 2.10
Longitudinal changes in skin-prick test reactivity over 2 years in a population of schoolchildren with respiratory symptoms. Clin Exp Allergy (1992) 2.06
Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. Br Med J (Clin Res Ed) (1987) 2.05
The natural history of respiratory symptoms in a cohort of adolescents. Am J Respir Crit Care Med (1998) 2.05
Fatal asthma attack during an inhalation challenge with ultrasonically nebulized distilled water. J Allergy Clin Immunol (1995) 2.04
A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. Biomarkers (2007) 2.02
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med (1995) 1.96
Transport of proteins into chloroplasts. The precursor of small subunit of ribulose bisphosphate carboxylase is processed to the mature size in two steps. Eur J Biochem (1984) 1.96
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax (2001) 1.95
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med (1984) 1.95
The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax (2008) 1.93
beta-adrenergic agonist resistance in normal human airways. Lancet (1977) 1.91
The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest (2001) 1.85
A proton gradient is required for the transport of two lumenal oxygen-evolving proteins across the thylakoid membrane. J Biol Chem (1991) 1.83
ALBINO3, an Arabidopsis nuclear gene essential for chloroplast differentiation, encodes a chloroplast protein that shows homology to proteins present in bacterial membranes and yeast mitochondria. Plant Cell (1997) 1.83
Fe-Chelate Reductase Activity of Plasma Membranes Isolated from Tomato (Lycopersicon esculentum Mill.) Roots : Comparison of Enzymes from Fe-Deficient and Fe-Sufficient Roots. Plant Physiol (1991) 1.83
Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. A longitudinal study. Am Rev Respir Dis (1989) 1.82
Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc Natl Acad Sci U S A (1980) 1.82
Natural history of asthma in childhood--a birth cohort study. Arch Dis Child (1991) 1.82
Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med (1996) 1.81
Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol (1993) 1.78
What's new about hay fever? Br Med J (Clin Res Ed) (1985) 1.76
Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis (1992) 1.75
Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am J Respir Crit Care Med (2000) 1.75
Effect of atopy on the natural history of symptoms, peak expiratory flow, and bronchial responsiveness in 7- and 8-year-old children with cough and wheeze. A 12-month longitudinal study [published errarum appears in Am Rev Respir Dis 1992 Aug;146(2):540]. Am Rev Respir Dis (1991) 1.73
Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. Br Med J (Clin Res Ed) (1984) 1.73
Peak flow based asthma self-management: a randomised controlled study in general practice. British Thoracic Society Research Committee. Thorax (1995) 1.72
Different airway inflammatory responses in asthmatic and healthy humans exposed to diesel. Eur Respir J (2004) 1.71
Inhibition of adenosine 5'-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide. Eur Respir J (1990) 1.70
Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax (2004) 1.69
Distribution of carbonate in thin sections of dental enamel. Caries Res (1968) 1.68
Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66
Associations between respiratory symptoms, bronchial response to methacholine, and atopy in two age groups of schoolchildren. Arch Dis Child (1989) 1.66
Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax (1997) 1.65
Respiratory symptoms in older people and use of domestic gas appliances. Thorax (1999) 1.65
Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? Am J Respir Crit Care Med (2001) 1.65
Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med (1997) 1.64
The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J (2006) 1.62
Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol (2014) 1.60
Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet (1991) 1.59
Human skin mast cells: their dispersion, purification, and secretory characterization. J Immunol (1987) 1.58
Variability and lack of predictive ability of asthma end-points in clinical trials. Eur Respir J (2002) 1.58
The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J (1999) 1.58
Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol (2005) 1.57
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J (2005) 1.56
Bacterial contamination of home nebuliser. Br Med J (Clin Res Ed) (1987) 1.55
Assessment of airway inflammation: an overview. Eur Respir J Suppl (1998) 1.55
The 18-kDa form of cat allergen Felis domesticus 1 (Fel d 1) is associated with gelatin- and fibronectin-degrading activity. Clin Exp Allergy (2000) 1.55
Predicting persistent disease among children who wheeze during early life. Eur Respir J (2003) 1.54
Proceedings: The inhibitory effect of insulin on pinnal anaphylaxis in the mouse. Br J Pharmacol (1974) 1.54
Serotypes and electropherotypes of human rotavirus in the USA: 1987-1989. J Infect Dis (1990) 1.54
Penetration of fluoride into natural plaque biofilms. J Dent Res (2005) 1.53
Computed tomography of projectile injuries. Clin Radiol (2008) 1.53